Patent: 4,076,828
✉ Email this page to a colleague
Summary for Patent: 4,076,828
| Title: | Method of treating helminthiasis by parenteral administration of sulfoxide derivatives of benzimidazoles |
| Abstract: | A method is provided for treating or inhibiting helminthiasis by parenterally administering sulfoxide derivatives of benzimidazoles having the structure ##STR1## wherein R.sup.1 is lower alkyl or phenyl-lower alkyl, R.sup.2 and R.sup.3 may be the same or different and are hydrogen or lower alkyl, R.sup.4 is cycloalkyl, and m is 0 to 3, n is 0 to 3, m + n being .ltoreq. 5. Pharmaceutical compositions for use in the above method are also provided. |
| Inventor(s): | Haugwitz; Rudiger D. (Titusville, NJ), Cruthers; Larry R. (Flemington, NJ) |
| Assignee: | E. R. Squibb & Sons, Inc. (Princeton, NJ) |
| Application Number: | 05/769,632 |
| Patent Claims: | see list of patent claims |
Details for Patent 4,076,828
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp. | ZOSTAVAX | zoster vaccine live | For Injection | 125123 | 05/25/2006 | ⤷ Try a Trial | 2039-09-23 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
